Prior COVID-19 infection is associated with increased Adverse Events (AEs) after the first, but not the second, dose of the BNT162b2/Pfizer vaccine
Rachael K. Raw, Jon Rees, Clive Kelly, Caroline Wroe, David Chadwick
Topics & Concepts
MedicineDosingCoronavirus disease 2019 (COVID-19)Adverse effectSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Limiting2019-20 coronavirus outbreakConfidence intervalInternal medicineEmergency medicineVirologyOutbreakDiseaseMechanical engineeringEngineeringInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyCOVID-19 Clinical Research Studies